.Zevra Therapies' rare illness medicine seems to be on the path to confirmation this autumn after ac...
.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics therapy failing has actually gone a $23...
.After greater than two decades of deal with neurodegenerative health conditions, Swiss biotech AC I...
.GSK has junked a phase 2 human papillomavirus (HPV) vaccine from its own pipe after deciding the re...
.OS Therapies will certainly provide on the NYSE American inventory exchange today using a $6.4 mill...
.ALX Oncology's phase 2 stomach cancer cells feedback cost has diminished. After seeing its CD47 blo...
.One More of Ionis Pharmaceuticals' crucial midphase readouts has disappointed expectations, motivat...
.While Biogen's pharma peers are hunting for late-stage resources with little threat, chief executiv...
.Instil Bio has been a biotech seeking a pipe after it ditched its own lead properties over the fina...
.Biogen has returned legal rights to a very early Alzheimer's illness plan to Denali Rehabs, going o...